Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

NCT05787587

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Cancer, +44 more
Locations
  • HonorHealth Research Institute Phoenix, Arizona, United States
  • The Angeles Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

NCT06428396

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • City of Hope - Phoenix ( Site 0006) Goodyear, Arizona, United States
  • Cedars Sinai Medical Center ( Site 0012) Beverly Hills, California, United States
  • Moores Cancer Center at UC San Diego Health ( Site 0025) La Jolla, California, United States
  • USC/Norris Comprehensive Cancer Center ( Site 0013) Los Angeles, California, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

NCT01463072

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Carcinoma, +11 more
Locations
  • City of Hope medical Duarte, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

NCT05458674

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • George Washington Medical Faculty Associates Washington D.C., District of Columbia, United States
  • New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States
  • Swedish Cancer Institute Issaquah, Washington, United States
View Trial Details
Active, Not Recruiting

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

NCT04711824

Conditions
Brain Diseases, Brain Metastases, Adult, Brain Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Memorial Healthcare System Hollywood, Florida, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

NCT04316117

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 104 locations
View Trial Details

Related conditions